Fig. 2From: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysisPrevalence of CrAg positivity among HIV-infected persons with CD4+ T cells< 200 cells/μL. Abbreviations: ES = effect sizeBack to article page